Evidence map›Paper›PMID 19474649›Full record

Trial reportAIDS (London, England)2009

Incident HIV and herpes simplex virus type 2 infection among men in Rakai, Uganda.

Aaron A R Tobian, Victor Ssempijja, Godfrey Kigozi, Amy E Oliver, David Serwadda, Frederick Makumbi, Frederick K Nalugoda, Boaz Iga, Steven J Reynolds, Maria J Wawer and 2 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS (London, England), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 4 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 4 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version).Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Aaron A R TobianDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Victor Ssempijja
Godfrey Kigozi
Amy E Oliver
David Serwadda
Frederick Makumbi
Frederick K Nalugoda
Boaz Iga
Steven J Reynolds
Maria J Wawer
Thomas C Quinn
Ronald H Gray
Johns Hopkins University · USMakerere University · UGRakai Health Sciences Program · UGGreater Baltimore Medical Center · US

Funding

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Male Circumcision Trial for HIV Prevention, Rakai-UgandaU01AI051171 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2002 to 2006
$8.9M
Immunopathogenesis Of Chlamydia trachomatis InfectionZIAAI000358 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI QUINN, THOMAS · 2009 to 2022
$7.0M
INTERNATIONAL STUDIES ON THE ACQUIRED IMMUNODEFICIENCY SYNDROMEZ01AI000361 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI QUINN, THOMAS · 1985 to 2008
$3.1M
International Training/Research in Population and Health, UgandaD43TW001508 · FIC · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2000 to 2010
$2.1M
SPECIAL POSTDOCTORAL RESEARCH PROGRAM IN AIDST22TW000015 · FIC · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SCOTT, GWENDOLYN B. · 1988 to 1999
–
FIC NIH HHS #5D43TW001508FIC NIH HHS #D43TW00015FIC NIH HHS D43 TW001508FIC NIH HHS T22 TW000015Intramural NIH HHS Z01 AI000361NIAID NIH HHS U01 AI051171NIAID NIH HHS #U1AI51171
6 · The paper itself

Abstract

objectiveHerpes simplex virus type 2 (HSV-2) infection is associated with an increased risk for acquiring HIV, but little is known about the temporal sequence of these infections.

design: Six thousand three hundred ninety-six men were evaluated for serologic HSV-2 and HIV infections and behaviors during a male circumcision trial in Rakai, Uganda.

methodsHIV and HSV-2 status were determined using enzyme-linked immunosorbent assays and confirmed by HIV-1 and HSV-2 western blots. A Poisson multivariable model was used to estimate adjusted incidence rate ratios of HIV acquisition associated with HSV-2 and other covariates.

resultsHIV incidence was 1.09/100 person-years and acquisition was associated with incident HSV-2 infection [adjusted incidence rate ratio (adjIRR) 5.28, 95% confidence interval (CI) 2.79-9.98], chronic HSV-2 infection (adjIRR 2.78, 95% CI 1.64-5.68), genital ulcer disease, urethral discharge, genital washing after intercourse, being unmarried, and being uncircumcised. Sixteen men acquired both HIV and HSV-2 during the trial: four acquired HIV first, three acquired HSV-2 first, and nine acquired both infections in the same follow-up interval.

conclusionThe findings suggest that unsafe sex places men at risk of both HIV and HSV-2 infections, and it is unclear whether HSV-2 acquisition is a cofactor for HIV infection or a marker of correlated sexual exposures. This reinforces the need for promotion of safe sex as the primary method of prevention of both viruses.

Indexed as

AdolescentAdultChronic DiseaseCircumcision, MaleEpidemiologic MethodsHerpes GenitalisHIV InfectionsHumansMaleMiddle AgedUgandaUnsafe SexYoung Adult

Identifiers

PMID19474649
PMCPMC2715553
OpenAlexW1994323316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.